• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.

作者信息

Costagliola S, Many M C, Stalmans-Falys M, Vassart G, Ludgate M

机构信息

Institut de Recherche Interdisciplinaire en Biologie Humaine et Nucleaire, Universite Libre de Bruxelles, Belgium.

出版信息

Mol Cell Endocrinol. 1995 Dec 29;115(2):199-206. doi: 10.1016/0303-7207(95)03691-1.

DOI:10.1016/0303-7207(95)03691-1
PMID:8824895
Abstract

In a previous study, we have described the induction of thyroid blocking (TBAB) and thyrotropin binding inhibiting antibodies accompanied by thyroiditis in female BALBc mice (H2d) immunised with the extra-cellular domain (ECD) of the human thyrotropin receptor (TSHR) expressed as a maltose binding protein (MBP) fusion. In the present study we have investigated the response induced in mice of varying MHC haplotype. Two groups of female NOD (H2g), CBA (H2k) and C57 (H2b) mice were immunised intra-peritoneally with MBP-ECD or MBP on days 0 (100 micrograms), 15, 30 and 43 (50 micrograms). Blood samples from individual mice were obtained on days 0, 22, 36 and 50 and assessed for thyroid binding inhibiting immunoglobulins (TBII), thyroid stimulating (TSAB) and TBAB. On day 50 the treated mice and five age/sex matched NOD mice were sacrificed, their thyroids removed, examined histologically and any infiltrate characterised. Induction of antibodies to the ECD was tested by ELISA in which plates had been coated with either MBP-ECD or an ECD-protein A fusion. All of the mice developed a strong antibody response to the relevant immunogen but none of them contained TBII, TSAB or TBAB activities. No lymphocytic infiltration of the thyroid glands of the CBA or C57 mice was observed. In contrast, all of the NOD mice displayed severe thyroiditis, whilst one of seven MBP-treated mice had moderate infiltration and none of five untreated controls. Immunohistochemical analysis revealed that the infiltrate was predominantly activated T helper cells with little evidence of B cells or the cytokines IL-10 or IL-4, indicating that a Th1 response had been induced, contrary to our findings in BALBc mice which mount a Th2 response. In conclusion we have shown that the type and extent of response induced by immunising with the TSHR varies in mice of differing genetic background. H2d mice develop thyroiditis and TBAB/TBII, H2g mice develop thyroiditis in the absence of functional TSHR antibodies, whilst H2b and H2k mice are resistant.

摘要

相似文献

1
The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.
Mol Cell Endocrinol. 1995 Dec 29;115(2):199-206. doi: 10.1016/0303-7207(95)03691-1.
2
Recombinant thyrotropin receptor and the induction of autoimmune thyroid disease in BALB/c mice: a new animal model.重组促甲状腺素受体与BALB/c小鼠自身免疫性甲状腺疾病的诱导:一种新的动物模型。
Endocrinology. 1994 Nov;135(5):2150-9. doi: 10.1210/endo.135.5.7956939.
3
Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R.用重组促甲状腺激素受体(TSH-R)免疫小鼠后诱导促甲状腺激素受体自身抗体和甲状腺炎。
Biochem Biophys Res Commun. 1994 Mar 15;199(2):1027-34. doi: 10.1006/bbrc.1994.1332.
4
Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB/c and NOD mice.将用人促甲状腺素受体致敏的同基因脾细胞转移至未致敏的BALB/c和NOD小鼠,引发甲状腺炎。
Endocrinology. 1996 Nov;137(11):4637-43. doi: 10.1210/endo.137.11.8895327.
5
Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease.自身免疫性甲状腺疾病中促甲状腺激素受体阻断抗体的患病率及临床相关性
Clin Exp Immunol. 2017 Sep;189(3):304-309. doi: 10.1111/cei.12980. Epub 2017 May 16.
6
Overexpression of the extracellular domain of the thyrotrophin receptor in bacteria; production of thyrotrophin-binding inhibiting immunoglobulins.促甲状腺激素受体细胞外结构域在细菌中的过表达;促甲状腺激素结合抑制性免疫球蛋白的产生。
J Mol Endocrinol. 1994 Aug;13(1):11-21. doi: 10.1677/jme.0.0130011.
7
Reevaluating thyrotropin receptor-induced mouse models of graves' disease and ophthalmopathy.重新评估促甲状腺素受体诱导的格雷夫斯病和眼病小鼠模型。
Endocrinology. 2005 Feb;146(2):835-44. doi: 10.1210/en.2004-1015. Epub 2004 Nov 11.
8
Development of an animal model of autoimmune thyroid eye disease.自身免疫性甲状腺眼病动物模型的建立。
J Immunol. 1999 Apr 15;162(8):4966-74.
9
The effect of thyrotropin-receptor blocking antibodies on stimulating autoantibodies from patients with Graves' disease.促甲状腺素受体阻断抗体对格雷夫斯病患者刺激性自身抗体的影响。
Thyroid. 2003 Dec;13(12):1153-61. doi: 10.1089/10507250360731569.
10
Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor.使用表达野生型或嵌合型人促甲状腺激素受体的CHO细胞通过各种检测方法分类的抗促甲状腺激素受体抗体亚型。
Thyroid. 1997 Feb;7(1):13-9. doi: 10.1089/thy.1997.7.13.

引用本文的文献

1
Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity.打破对甲状腺抗原的耐受性:甲状腺自身免疫中概念的改变。
Endocr Rev. 2014 Feb;35(1):59-105. doi: 10.1210/er.2013-1055. Epub 2013 Dec 4.
2
Pathogenesis of ophthalmopathy in autoimmune thyroid disease.自身免疫性甲状腺疾病中眼病的发病机制。
Rev Endocr Metab Disord. 2000 Jan;1(1-2):87-95. doi: 10.1023/a:1010020621687.
3
Cytokines, IgG subclasses and costimulation in a mouse model of thyroid autoimmunity induced by injection of fibroblasts co-expressing MHC class II and thyroid autoantigens.
通过注射共表达II类主要组织相容性复合体和甲状腺自身抗原的成纤维细胞诱导的小鼠甲状腺自身免疫模型中的细胞因子、IgG亚类和共刺激
Clin Exp Immunol. 2000 Nov;122(2):170-9. doi: 10.1046/j.1365-2249.2000.01362.x.
4
Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions.利用缺乏血清学显性区域的促甲状腺激素受体诱导小鼠甲状腺炎。
Clin Exp Immunol. 1998 Jul;113(1):119-25. doi: 10.1046/j.1365-2249.1998.00627.x.